egs_brachy is a versatile and fast Monte Carlo (MC) code for brachytherapy applications. It is based on the EGSnrc code system, enabling simulation of photons and electrons. Complex geometries are modelled using the EGSnrc C++ class library and egs_brachy includes a library of geometry models for many brachytherapy sources, in addition to eye plaques and applicators. Several simulation efficiency enhancing features are implemented in the code. egs_brachy is benchmarked by comparing TG-43 source parameters of three source models to previously published values. 3D dose distributions calculated with egs_brachy are also compared to ones obtained with the BrachyDose code. Well-defined simulations are used to characterize the effectiveness of many efficiency improving techniques, both as an indication of the usefulness of each technique and to find optimal strategies. Efficiencies and calculation times are characterized through single source simulations and simulations of idealized and typical treatments using various efficiency improving techniques. In general, egs_brachy shows agreement within uncertainties with previously published TG-43 source parameter values. 3D dose distributions from egs_brachy and BrachyDose agree at the sub-percent level. Efficiencies vary with radionuclide and source type, number of sources, phantom media, and voxel size. The combined effects of efficiency-improving techniques in egs_brachy lead to short calculation times: simulations approximating prostate and breast permanent implant (both with (2 mm) 3 voxels) and eye plaque (with (1 mm) 3 voxels) treatments take between 13 and 39 s, on a single 2.5 GHz Intel Xeon E5-2680 v3 processor core, to achieve 2% average statistical uncertainty on doses within the PTV. egs_brachy will be released as free and open source software to the research community.
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Introduction
Brachytherapy plays an important role in the treatment of various cancers, including breast, prostate, gynecological, and ocular cancers (Thomadsen et al 2008) . In cancer centers, doses for brachytherapy treatments are computed using the formalism described by Task Group 43 (TG-43) of the American Association of Physicists in Medicine (AAPM) (Rivard et al 2004) : doses are calculated as the superposition of dose distributions for individual sources which were pre-calculated assuming a water environment. The speed of TG-43 dose calculations comes at the expense of accuracy. These simplified calculations ignore factors which can significantly impact dose distributions, such as tissue inhomogeneities, the presence of nearby objects with elemental compositions different from water, and the attenuation of photons by the seeds themselves (see Beaulieu et al (2012) and references therein).
With the goal of reducing differences between calculated and delivered doses, momentum is growing for adoption of model-based dose calculation algorithms (MBDCAs) in brachytherapy. A number of codes have been developed to carry out advanced model-based dose calculations for brachytherapy; see the report of AAPM Task Group 186 and references therein, Chibani and Williamson (2005) , Taylor et al (2007) , Thomson et al (2010) , Afsharpour et al (2012) , Chibani and Ma (2014) and Bonenfant et al (2015) . Two MBDCA options are available in commercial treatment planning systems: Acuros (a gridbased Boltzmann equation solver) in Brachy Vision 1 and ACE (a collapsed cone superposition/convolution method) in Oncentra Brachy 2 (Papagiannis et al 2014) . Although the Monte Carlo (MC) technique has long been recognized a highly accurate computational dosimetry method, its routine clinical use has been limited due to long calculation times. Further, many brachytherapy-specific MC codes are not widely available.
BrachyDose (Taylor et al 2007 , Thomson et al 2010 , an EGSnrc (Kawrakow et al 2011) user code which uses the multi-geometry package by (Yegin 2003) , was developed to address this need. However, in the years since the development of BrachyDose, the highly versatile, open source, and actively-maintained EGSnrc C++ class library (Kawrakow et al 2009) (called egs++) was released. This motivated the development of egs_brachy, a modern EGSnrc application using egs++ for modelling geometries and particle sources, designed specifically for brachytherapy applications. In addition, egs_brachy also led to several enhancements to the general-purpose egs++ library in the form of new geometry and shape classes. Figure 1 provides an overview of the egs_brachy application. Like most other distributed EGSnrc user codes, egs_brachy relies on a text-based input file to define all aspects of the simulation. egs_brachy can be used for a comprehensive set of brachytherapy simulations, such as dose calculations, generation of phase-space data and calculation of particle spectra. egs_brachy also incorporates features to enhance simulation efficiency, including efficient radiation transport and geometry modelling, calculation of collision kerma using the tracklength estimator, phase-space sources, particle recycling, and variance reduction techniques for electronic brachytherapy. A library of pre-defined source, applicator, and phantom geometries is distributed with the system.
The current work provides benchmarks of the code against other published data, and assesses the efficiency gains from various techniques implemented in the code. egs_brachy is benchmarked by reproducing previously published TG-43 source parameters for three brachytherapy source models and comparing 3-D dose distributions calculated using egs_brachy and BrachyDose. The various egs_brachy features to enhance simulation efficiency are characterized through example simulations and calculation times for realistic clinical scenarios are presented.
Methods

The egs_brachy application
As egs_brachy is an EGSnrc application, both photon and electron transport may be modelled. This permits simulation of electronic sources (for example, miniature x-ray tubes and betaemitting eye plaques) in addition to photon (radionuclide) brachytherapy sources. Although egs_brachy is capable of modelling electron transport, the low energy of photons from brachytherapy sources means that dose is well approximated by collision kerma for most situations of interest. Hence, generally only the simulation of photon transport is necessary and electron transport is turned off by appropriate choice of the electron cutoff energy. Complex geometries can be modelled using the built-in elementary and composite geometries of egs++. A rectilinear phantom may be defined by a CT dataset using the egsphant file format also used with the EGSnrc user code DOSXYZnrc. The code scores dose or collision kerma in rectilinear voxels or in spherical or cylindrical shells 3 . A fast envelope geometry class, EGS_AutoEnvelope, is used to inscribe one or more copies of source geometries inside a phantom. Voxels containing part of a source geometry are automatically identified during the initialization of the simulation geometry. During particle transport, if a voxel contains no source, then there is no check of the boundaries of source geometries. The distribution of radioactivity within a source is defined by sampling random points from a user-specified shape. Two new egs++ shape classes, EGS_ConicalShellStackShape and EGS_SphericalShellShape, sample random points within conical and spherical shells, respectively. The additions to egs++ will be available as part of the next major release of the EGSnrc distribution. egs_brachy has three run modes which permit different types of simulations: normal, superposition, and volume correction only. The default run mode for simulations is normal. The superposition run mode may be used with more than one brachytherapy source, but only one source is 'active' at a time. This run mode is suitable for simulating HDR treatments (in which a single source steps through dwell positions) and for removing interseed effects. The volume correction only run mode calculates volume corrections needed when objects occupy part of a scoring voxel, outputs the results, and then quits; no radiation transport is done.
At low photon energies, dose can be approximated as collision kerma, which egs_brachy scores using a tracklength estimator (see Williamson (1987) ). For consistency, this requires use of mass energy absorption coefficients for each material calculated with the same cross sections as used for the simulation of radiation transport (for example, using the EGSnrc application 'g'). egs_brachy can also score dose using interaction scoring which is much less efficient but can be used to account for electron transport where charged particle equilibrium does not exist.
Whether dose is approximated as collision kerma or absorbed dose is calculated, statistical uncertainties on dose are evaluated using history-by-history statistics (Walters et al 2002) . Dose in voxel j is output normalized as dose per effective starting particle, N eff (table 1). For simulations in which starting particles are initiated within the radioactivity distribution within the source (herein referred to as 'ab initio'), N eff is just the number of histories, N h . When a phase-space source or the particle recycling feature are used, N eff is the number of independent histories that would have to be simulated in an ab initio simulation to obtain the same number of scoring particles.
At the request of the user, dose is scored separately for primary, single-scattered, and multiple-scattered particles according to the Primary Scatter Separated (PSS) dose formalism (Russell et al 2005) . egs_brachy can tabulate phase-space data on the surface of a source for all particles emitted from the source. Three spectrum scoring options are available in egs_brachy: the first is an absolute count of the particles escaping a source; the second is an energy-weighted spectrum of particles scored on the surface of a source; and the third is an energy fluence spectrum scored in a voxel.
Features to enhance simulation efficiency
In addition to the tracklength estimator to score collision kerma and the EGS_AutoEnvelope geometry class mentioned above, other features to enhance simulation efficiency are discussed in the current section. The metric to quantify simulation efficiency is
3 Using an addition to the egs++ geometry library developed in conjunction with egs_brachy.
M J P Chamberland et al Phys. Med. Biol. 61 (2016) 8214 where t is the total CPU simulation time for transport and scoring needed to compute a chosen quantity with uncertainty s, but t does not include the time to initialize the simulation and the geometry, output the results, etc.
For simulations of n s > 1 sources of the same model with the normal run mode, it is not necessary to repeat the simulation of photons within a source for every history. With the particle recycling feature, the first source in the simulation acts as a particle generator. Particles initiated in this source are tracked until they are either absorbed within it or they escape the source encapsulation. An escaping particle is translated and initiated for each source at the same relative position as it escaped the first source. The recycled particles can optionally be randomly rotated about the source axis before being reinitiated at each source location. Each generated particle may be recycled more than once (n r times) at each source location; in this case, the rotation is not optional and particles are rotated before each reuse. The computation of statistical uncertainties accounts for correlations between recycled particles: the history counter is incremented by one for each set n n s r of recycled particles to preserve the history-by-history statistics (table 1) . A phase-space source can be used instead of initiating particles within a source geometry. A user-specified number of particles, N 1 , is initiated on the surface of sources from the phasespace data. If the user wishes to simulate more starting particles than there are data for in the phase space (i.e., N N 1 e mit > ), it is recommended that particle recycling be used in conjunction with the phase-space source to account for correlations between particles from the same primary history (table 1) .
The standard EGSnrc variance reduction techniques of bremsstrahlung cross section enhancement (BCSE), uniform bremsstrahlung splitting (UBS), Russian roulette, and range rejection are available to enhance simulation efficiency of electron transport. The BCSE feature allows the user to specify a factor f enh by which to scale up the bremsstrahlung production cross section in the target material. With UBS, each generated bremsstrahlung photon is split into N split photons (with N split specified by the user). If BCSE or UBS are used, then Russian roulette is automatically activated and secondary charged particles produced have a survival probability of f N 1 enh split /( ). Range rejection of charged particles is enabled by default in the phantom voxels.
Simulations
Simulations with egs_brachy are carried out for benchmarking, characterization of simulation efficiencies, and determination of calculation times with clinical configurations (table 2) . In all calculations, the photon cutoff energy is set to 1 keV and electron transport is generally not modelled. Rayleigh scattering, bound Compton scattering, photoelectric absorption, and fluorescent emission of characteristic x-rays are all modelled. Atomic transitions available in the Livermore Evaluated Atomic Data Library (EADL) (Perkins et al 1991) are modelled explicitly 4 . Photon cross sections are from the XCOM database (Berger and Hubbell 1987) . Mass-energy absorption coefficients are calculated using the EGSnrc user code g. Photon 4 But the M and N shells were treated in an average way for the comparisons reported here. , with elemental composition from Woodard and White (1986) . b Egsphant model of the eye from Lesperance et al (2014) ; includes non-water media for ocular structures and surrounding tissues. c Egsphant model of the breast from Sutherland et al (2011) ; includes gland and adipose tissues. d Virtual patient phantom from CT data, with tissue assignment scheme (TAS) from Miksys et al (2016a) . e Virtual patient phantom from CT data from Peppa et al (2016) , with TAS from Miksys et al (2016a) . f Virtual patient phantom from CT data, with TAS from Miksys et al (2016a) . g Number of dwell positions. spectra from the NNDC (Brookhaven National Laboratory, National Nuclear Data Center) ( 103 Pd and 192 Ir) are used to sample initial photon energies and probabilities. For 125 I, the photon spectrum from the NCRP Report 58 (1985) is used since Rodriguez and Rogers (2013) demonstrated that using the NCRP spectrum leads to much better agreement with calculated spectra and is consistent with the spectrum recommended by the BIPM for use by primary standards labs (BIPM 2011) . Calculations are carried out on a single 2.5 GHz Intel Xeon E5-2680 v3 processor core, with egs_brachy compiled using gcc version 4.1.2 20080704. For calculation of the efficiency, ε, (equation (1)) the uncertainty s 2 is taken as the quadrature sum of percent statistical uncertainties on all doses to scoring voxels in the region of interest, not only those with dose above some threshold.
2.3.1. Benchmarking. egs_brachy is benchmarked against BrachyDose, which has been extensively validated in the past (Taylor et al 2007 , Taylor and Rogers 2008a , 2008b , Thomson et al 2008 , Rivard et al 2011 , Ballester et al 2015 . TG-43 source parameters are calculated for three source models using an approach similar to that used by Rogers (2008a, 2008b) In addition, dose distributions for configurations 'j' and 'm' are calculated with egs_ brachy and BrachyDose. Configuration 'j' approximates a prostate LDR treatment with 100 125 I seeds arranged in a 5 4 5 × × grid. Nominal source center-to-center distances of 7 mm in the x and y-directions and 8 mm in the z-direction are perturbed randomly by up to 0.5 mm. Configuration 'm' includes a COMS 16 mm plaque (Thomson et al 2008) containing 13 125 I seeds; BrachyDose dose distributions were previously shown to agree within statistical uncertainties with published MCNP5 results (Rivard et al 2011) . Comparisons of the 3D dose distributions for configurations 'j' and 'm' are done with the approach of Kawrakow and Fippel (2000) : a function which separates systematic uncertainties from expected statistical uncertainties is fit to the distribution of voxel-by-voxel dose differences (in units of the combined uncertainty on doses in each voxel). The function is the probability distribution f(x) to find a voxel with dose difference x and is given by:
where 1 α and 2 α are the fraction of voxels that have a systematic difference of 1 ∆ and 2 ∆ , respectively.
Characterization of simulation efficiency.
Single radionuclide source. For each source model studied (see table 2), a single source is modelled at the center of configurations 'c' ( 103 Pd and 125 I) and 'd' ( 192 Ir). A second set of simulations is performed with the source at the center of configurations 'e', 'f', and 'g', with phantom dimensions motivated by consideration of energy deposition about a single source. The dimensions were determined using results for dose scored in concentric spherical shells about a single source at the center of a large water sphere (figure 2). The rectilinear phantoms have side length 2R 75 , where R 75 is the radius of the sphere within which 75% of the energy is deposited. Similarly, the scoring regions have side length 2R 50 , where R 50 is the radius of the 50% energy deposition sphere.
Prostate permanent implant. The prostate configuration used for benchmarking ('j', with 100 125 I seeds) is used again for characterization of efficiency gains. In addition, configurations 'h' and 'i' are also used, with the same arrangement of 125 I seeds.
Eye plaque. Simulations are performed with configurations 'k', 'l', and 'm', and include a COMS 16 mm plaque containing 13 125 I seeds (Thomson et al 2008) . For calculation of efficiency, only the voxels containing tumor tissue in the egsphant ('k') and the corre sponding voxels in the water phantoms ('l', 'm') are considered. The size of the target volume is 0.2995 cm 3 (2396 voxels) and 0.414 cm 3 (414 voxels) for 'l' and 'm', respectively. (Taylor et al 2006) . Using monoenergetic 50 keV electrons as starting particles, the following simulations are performed: ab initio (electron transport within the source only and photon transport only elsewhere in the phantom) and also using BCSE and UBS with Russian roulette employing the optimum parameters reported by Ali and Rogers (2007) for the (1 mm) 3 grid of voxels they considered: f 500 enh = and N 100 split = . In addition, the phase space of photons emitted from the source is scored and used to initiate a simulation.
2.3.3. Calculation times for clinical configurations. Configurations 'p', 'q', and 'r' are used to illustrate realistic egs_brachy timing in a clinical setting to reach a given metric (2% average statistical uncertainty on doses to the PTV; 5% on doses to the organs at risk). Configuration 'p' corresponds to a breast LDR treatment; 'q' corresponds to a breast HDR treatment; and 'r' corresponds to a prostate LDR treatment. Only voxels with doses greater than 25% of the prescription dose are considered in the calculation of the uncertainties in the volumes of interest.
Results and discussion
Benchmarking
A summary of benchmarking results is shown in figure 3 which displays radial dose functions and anisotropy functions at 1 cm, as calculated by egs_brachy and BrachyDose. Dose-rate constants are shown in table 3. Agreement within uncertainties between the two codes is found for all TG-43 source parameters, as well as agreement within uncertainties with measured dose rate constants.
The distributions of dose differences between egs_brachy and BrachyDose 3D dose distributions for the prostate ('j') and eye plaque ('m') configurations are shown in figure 4. Equation (2) is fit to each distribution and the parameters 1 α , 1 ∆ , 2 α , and 2 ∆ are extracted, if applicable. For 99% of the voxels in the prostate case, the systematic difference is a small fraction (0.03) of the average combined uncertainty of the two dose distributions (0.6%). For 14% of the voxels in the eye plaque case, the systematic difference is 0.77 of the average combined uncertainty (0.6%), which corresponds to a systematic difference of 0.46%. For both simulation geometries, the doses to the remaining voxels agree between the two codes within statistical uncertainties. The systematic differences observed are either much smaller than other typical Monte Carlo systematic uncertainties (which add up in quadrature to 1.5-2.5%) (Rivard et al 2004, Rodriguez and Rogers 2014) or they affect a small fraction of voxels (14%). Note that the results from the fit are sensitive to the width of the bins used. For example, using bins of width 0.2 (instead of 0.1) yields 103 Pd, a 1% square-root quadrature sum uncertainty for the (2 cm) 3 grid of (1 mm) 3 voxels will be achieved in 89 s for phase-space source simulations and 184 s for ab initio simulations. For any phantom considered, the most substantial efficiency gains from using a phase-space source are achieved for the lower-energy sources for which a significant fraction of photons are absorbed within the source. For a given radionuclide, there are no significant differences in efficiencies between different source models (results not shown). Efficiency improvements are less dramatic between the three radionuclides for the phantoms of varying sizes ('e', 'f', 'g'). Rodriguez and Rogers (2014) . b Taylor and Rogers (2008b) . c Nath et al (2000) . d Kennedy et al (2010) . (2) is shown along with the fitted parameters. 3 voxels) and increases with the number of voxels as voxel size decreases. With EGS_ AutoEnvelope, simulation times are up to 4.6 times shorter (100 seeds in a PTV filled with (1 mm) 3 voxels). The time to identify phantom voxels containing source geometries varies from 0.01 s (single seed) to 1 s (100 seeds in (1 mm) 3 voxels), which is negligible compared to the CPU time spent on radiation transport. The efficiency gain of using EGS_AutoEn-velope increases with the number of seeds and is larger for smaller voxels (for which a larger number of voxels do not contain source geometries). Using EGS_AutoEnvelope provides the advantage of calcul ation times that are effectively independent of the number of seeds modelled. For a single source or a single voxel simulation, using EGS_AutoEn-velope results in slightly slower calculations, but those configurations are not typically relevant in a clinical setting. Table 6 presents efficiencies for the various example simulation geometries with  125 I,  103 Pd,  or 192 Ir sources. Tracklength rather than interaction scoring of collision kerma results in efficiency gains of factors of 10 to more than 300. Efficiency gains from the phase-space source and recycling features of egs_brachy are more modest than those for going from interaction scoring to tracklength scoring but are still considerable in achieving clinically-reasonable calcul ation times. Efficiency gains vary with radionuclide, source model, number of sources, simulation type, phantom media and extent, and voxel size.
For prostate simulations, simulations in prostate medium ('i') or in water ('j') with the same (2 mm) 3 voxel grid have comparable efficiencies (table 6) . Efficiencies are expected to vary somewhat with phantom medium due to voxel-by-voxel cross section variations affecting radiation transport and energy deposition. Hence efficiencies are not identical for prostate Table 5 . Variation in prostate simulation times (configurations 'h' and 'i') with the number of 125 I seeds and voxel sizes (with tracklength scoring). CPU times for radiation transport (with or without the use of the EGS_AutoEnvelope geometry class) and the square root of the quadrature sum of percent statistical uncertainties on doses to voxels within the PTV are given for simulations of 4 10 simulations in water or non-water media with the same voxel grid. However, the comparable efficiencies in water and non-water media in table 6 are in contrast with the results of Afsharpour et al (2012) who report time differences of factors of two or more for water versus non-water simulations using their Geant4-based code ALGEBRA for prostate and breast LDR simulations. This is due to the fact that Geant4 (ALGEBRA) does not look up cross sections when crossing voxel boundaries for the homogeneous water calculations, but it does for the heterogeneous media calculations. In contrast, EGSnrc (egs_brachy) looks up cross sections for each voxel no matter the simulation geometry and hence calculation time does not change substantially. Simulation efficiency is enhanced over ab initio simulations by factors of 1.08-2.18 using phase-space sources and by factors of 1.42-2.43 using particle recycling without rotation of the particles around the long axis of the source. In many cases, efficiencies for simulations with recycling are comparable to those using a phase-space source. Hence, recycling is effective at improving simulation efficiency without the need to generate and store large phasespace files since, for many seeds, the overall time spent simulating transport inside seeds is relatively small when recycling. In general, rotating recycled particles does not significantly improve efficiency over recycling particles without rotation. Recycling particles more than once at each source location does not lead to further efficiency gains.
The combined effects of the different egs_brachy features to enhance simulation efficiencies result in short simulation times which can be deduced from the efficiencies presented in table 6. For more accurate estimates of egs_brachy timing, the simulations were run until 2% statistical uncertainty on doses in the volumes of interest was reached. In general, the most Table 6 . Efficiencies for simulations of prostate, eye, and breast brachytherapy with configurations described in table 2. Collision kerma is scored using tracklength scoring in all cases, except for the column labeled Interaction. For Recycling, particles are initiated within the first seed and emitted particles are reinitiated once at other seed locations, without rotation of the recycled particles around the source. The phase space is not recycled. The efficiency relative to that for the ab initio simulation is indicated in parentheses. The time in seconds to achieve = s 1% is ε / 1 . Times for simulations employing a phase-space source do not include the time to generate the phase-space data. efficient simulations are those with tracklength scoring and employing a phase-space source; the simulation times quoted in this paragraph are for these calculations. Times in parentheses in the next sentence indicate the total time, including initialization of the simulation and geometry, outputting results, etc. Simulations achieving 2% statistical uncertainty in the prostate with (2 mm) 3 voxels ('i') take 10 s (13 s); (1 mm) 3 voxels ('h') take 57 s (63 s). Simulations of the eye plaque in a water phantom with (1 mm) 3 voxels ('m') take less than 15 s (22 s) to achieve 2% uncertainty; with a more detailed phantom with smaller voxels ('l'), simulations take at most 79 s (95 s). For breast 103 Pd calcul ations ('o'), 2% uncertainty in (2 mm) 3 voxels comprising the PTV take less than 35 s (39 s); similarly for breast 192 Ir calculations ('o'), 2% uncertainty is reached in 147 s (151 s).
Simulation
Some of the individual features used to enhance egs_brachy simulation efficiency have been employed in other MC brachytherapy-specific codes. In their photon-specific code for prostate implants, MCPI, Chibani and Williamson (2005) employed a tracklength estimator for scoring dose and phase-space data as source of initial particles in simulations, in addition to geometric considerations (discretizing internal seed structure, simplified seed models rather full source geometry modelling, voxel-indexing of seeds). They employed ray tracing to enhance MCPI efficiency rather than using analog photon transport (Chibani and Williamson 2005 )-the latter is employed in egs_brachy. In the PTRAN code (Williamson 1987, Li and Williamson 1992) , use of a tracklength estimator over interaction scoring results in 10 to 100-fold increase in efficiency (Hedtjärn et al 2002) , similar to results obtained with egs_brachy. Afsharpour et al (2012) also reported on a brachytherapy-specific Geant4-based MC code, ALGEBRA, which employs a phase-space source and tracklength estimator to score collision kerma; however, efficiency gains or time reductions due to these features are not reported. Characterization of efficiency gains is highly dependent on both the code in which the features are implemented and the code used for comparison.
The present characterization of features to enhance efficiency has been done within the same code by comparing efficiencies for simulations with and without the features. This performance assessment generalizes beyond any one code. With the development and adoption of MBDCA for brachytherapy, other codes may benefit from the techniques presented herein to assess calculation efficiency. For example, other codes may use the same idealized configurations used in this study (prostate and breast permanent implants, eye plaque, etc) to conduct speed benchmarks.
3.2.3. Electronic brachytherapy. Finally, consider the 50 kV electronic brachytherapy configuration ('c'). Using a phase-space source, the efficiency is 5.0 10 3 × − s −1 , which is comparable to the efficiencies reported for radionuclide sources in table 6. The efficiency gain factor is 1.11 10 4 × over the ab initio simulation, which indicates simulation of radiation transport within the source is very time-consuming. The simulation with electrons initialized within the source but with BCSE ( f 500 enh = ) and UBS (N 100 split = ) is 2.1 10 3 × times more efficient than the ab initio analog simulation, but still an order of magnitude less efficient than using a phase-space source (ignoring the time to calculate the phase-space file). An ab initio simulation of the x-ray source takes up to 153 h to achieve 2% uncertainty on doses to the (1 mm) 3 voxels in the (2 cm) 3 cube, whereas simulations with the phase-space source take 50 s and those with BCSE and UBS take 4.5 min. Efficiency gains of range rejection are negligible for this particular configuration. Although the efficiency gains of using BCSE and UBS are smaller than using a phase-space source, the usefulness of the variance reduction techniques should not be underestimated for research and development purposes (for example, when fine-tuning new x-ray source parameters to match experimental measurements). The ability to model electron sources such as miniature x-ray tube and beta emitting eye plaques is a strength of the egs_brachy code system compared to photon-specific brachytherapy codes. Table 7 shows calculation times for the three clinical configurations considered ('p', 'q', 'r'). Most total times when egs_brachy is run on one processor core are below 1 min, which includes the time for simulation and geometry initialization, outputting and combining results, etc. The breast HDR treatment takes 4 min to reach 5% uncertainty on doses to the skin. The time for initializing the simulation and the geometry and for outputting results depends on factors such as disk read and write speeds, CPU speed, number of voxels and media in the geometry, etc. Shorter simulation times can be achieved by running calculations in parallel. Note that times will vary with patient and treatment (location and number of seeds, radionuclide, volumes of PTV and organs at risk, proximity of organs at risk to sources, etc). egs_brachy calculation times are comparable or faster to those achievable with other brachytherapy-specific Monte Carlo codes on CPUs (Chibani and Williamson 2005 , Afsharpour et al 2012 , Chibani and Ma 2014 . However, calculation times depend on CPU used, so a direct comparison to other codes is meaningless unless performed on similar hardware. We note that egs_brachy is comparable in speed or faster than BrachyDose (Taylor et al 2007 , Thomson et al 2010 , but timing results were never comprehensively reported in the literature for the latter.
Calculation times for clinical configurations
Conclusions
egs_brachy dose distributions agree with BrachyDose on a sub-percent level. TG-43 param eters calculated with egs_brachy also agree within uncertainties with published values. For photon sources, it is found that the largest gain in simulation efficiency comes from using a tracklength estimator to score collision kerma (factor of 10 to 300 over interaction scoring). The EGS_AutoEnvelope geometry class for simulations including multiple seeds and small voxels improves efficiency by a factor of up to 4.6 for 100 seeds in (1 mm) 3 voxels. Use of a phase-space source or of particle recycling can further increase the efficiency by a factor of 2. For electronic brachytherapy, the efficiency is improved by more than four orders of magnitude with the use of a phase-space source. BCSE and UBS variance reduction techniques increase the efficiency by a factor of 2.1 10 3 × over ab initio simulations. Resulting egs_brachy calculation times for realistic LDR clinical scenarios are below 1 min using a single processor core (below 4 min for HDR). As the brachytherapy community moves towards greater clinical adoption of model-based dose calculations for brachytherapy, it is the authors' hope that egs_brachy will contribute to advancing dosimetry. To that end, egs_brachy will be released as free and open source software to the scientific community for research purposes. (see http://physics.carleton.ca/clrp/egs_brachy)
